Pegylated Recombinant Human Erythropoietin

Information about Pegylated Recombinant Human Erythropoietin

Pegylated recombinant human erythropoietin uses

Pegylated Recombinant Human Erythropoietin is used in the treatment of anemia due to chemotherapy and anemia due to chronic kidney disease.

How pegylated recombinant human erythropoietin works

Pegylated Recombinant Human Erythropoietin contains a man-made form of Erythropoietin, a hormone that is produced mainly by specialized cells in the kidney. It acts on red blood cells to protect them against destruction. At the same time, it stimulates stem cells of the bone marrow to increase the production of red blood cells and provides homeostasis in oxygen delivery to body tissue.

Common side effects of pegylated recombinant human erythropoietin

Available Medicine for Pegylated Recombinant Human Erythropoietin

  • ₹3350 to ₹8938
    Intas Pharmaceuticals Ltd
    4 variant(s)

Content on this page was last updated on 01 February, 2021, by Dr. Varun Gupta (MD Pharmacology)